Home

news and events

MIT and MGH Form Strategic Partnership to Address Major Challenges in Clinical Medicine

Thursday, October 16, 2014

MIT AND MGH FORM STRATEGIC PARTNERSHIP TO ADDRESS MAJOR CHALLENGES IN CLINICAL MEDICINE

October 16, 2014

First set of grants support projects designed to improve diagnostic accuracy and cost-effectiveness.

A novel partnership between MIT and Massachusetts General Hospital (MGH) is addressing three major challenges in clinical medicine: improving the diagnosis of disease; developing new approaches to prevent and treat infectious and autoimmune diseases; and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases.

While individual collaborations between MIT and MGH investigators are nothing new, this formalized strategic partnership is designed to accelerate the development of diagnostic tools and therapies.  

“MIT and MGH have uniquely synergistic and complementary strengths,” says Arup Chakraborty, the Robert T. Haslam Professor of Chemical Engineering, Chemistry, and Biological Engineering at MIT, and director of the MIT Institute for Medical Engineering and Science. “I believe that developing the cost-effective diagnostic tools, therapies, and vaccines needed to overcome some of the daunting challenges facing human health today can be achieved by bringing approaches from engineering and basic science together with clinical medicine and that a strategic partnership between our institutions could achieve much more toward advancing human health.”  Read more...